Inhibition impairment in frontotemporal dementia, amyotrophic lateral sclerosis, and Alzheimer's disease: clinical assessment and metabolic correlates.


Journal

Brain imaging and behavior
ISSN: 1931-7565
Titre abrégé: Brain Imaging Behav
Pays: United States
ID NLM: 101300405

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 12 5 2018
medline: 13 11 2019
entrez: 12 5 2018
Statut: ppublish

Résumé

The ability to reject an automatic tendency, i.e. inhibition, has been linked to the prefrontal cortex, but its neural underpinnings are still controversial. Neurodegenerative diseases represent an interesting model to explore this issue, given its frequent impairment in these disorders. We investigated the inhibitory impairment and its neural basis using four different tests, which evaluate the presence of inhibitory dysfunction (Stroop test, Hayling test, and two graphical perseveration tests), and assessed their correlation with brain metabolism using

Identifiants

pubmed: 29748771
doi: 10.1007/s11682-018-9891-3
pii: 10.1007/s11682-018-9891-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

651-659

Auteurs

Jordi A Matías-Guiu (JA)

Department of Neurology. Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Profesor Martin Lagos St s/n, 28040, Madrid, Spain. jordimatiasguiu@hotmail.com.

María Nieves Cabrera-Martín (MN)

Department of Nuclear Medicine. Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain.

María Valles-Salgado (M)

Department of Neurology. Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Profesor Martin Lagos St s/n, 28040, Madrid, Spain.

Teresa Rognoni (T)

Department of Neurology. Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Profesor Martin Lagos St s/n, 28040, Madrid, Spain.

Lucía Galán (L)

Department of Neurology. Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Profesor Martin Lagos St s/n, 28040, Madrid, Spain.

Teresa Moreno-Ramos (T)

Department of Neurology. Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Profesor Martin Lagos St s/n, 28040, Madrid, Spain.

José Luis Carreras (JL)

Department of Nuclear Medicine. Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain.

Jorge Matías-Guiu (J)

Department of Neurology. Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Profesor Martin Lagos St s/n, 28040, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH